...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Endocyte Valuation
Reply New Message
Prev Message Back To Forum Threaded View Next Message

This tiny biotech spun a quick $2 billion from $12 million

Marketwatch story on Lu-PSMA-617 Endocyte/Novartis. Thanks to Chrispi on BiOasis Stockhouse page for sharing.

BDAZ

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply